[Translation] A randomized, double-blind, placebo-controlled, multicenter superiority trial to evaluate the efficacy and safety of Podesan enema
研究在中国活动性左半结肠溃疡性结肠炎(UC)患者4周的治疗中,与安慰剂灌肠剂相比,颇得斯安灌肠剂(1 g/100 ml QD)的有效性和安全性,之后是最长28周的颇得斯安灌肠剂和/或颇得斯安片剂的开放性扩展期治疗
[Translation] To investigate the efficacy and safety of Podesan enema (1 g/100 ml QD) compared with placebo enema in Chinese patients with active left-sided ulcerative colitis (UC) for 4 weeks, followed by an open-label extension period of Podesan enema and/or Podesan tablets for up to 28 weeks.